Search Results Search Sort by RelevanceMost Recent Podcast Nov 2022 Author Interview: “Necessity for and Limitations of Price Transparency in American Health Care” Dr Harold A. Pollack joins Ethics Talk to discuss his article: “Necessity for and Limitations of Price Transparency in American Health Care.” Case and Commentary Aug 2022 Underrecognition of Dysmenorrhea Is an Iatrogenic Harm Zainab Doleeb, MD, Liam G. McCoy, MD, MSc, Jazleen Dada, MBChB, and Catherine Allaire, MD Underrecognition and lack of awareness about how to help patients with painful menstruation constitute injustice and a health care harm. AMA J Ethics. 2022;24(8):E740-747. doi: 10.1001/amajethics.2022.740. Podcast Aug 2022 Author Interview: “Underrecognition of Dysmenorrhea Is an Iatrogenic Harm” Dr Liam G. McCoy joins Ethics Talk to discuss his article, coauthored with Drs Zainab Doleeb, Jazleen Dada, and Catherine Allaire: “Underrecognition of Dysmenorrhea Is an Iatrogenic Harm.” Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. Medicine and Society Oct 2003 Access to Mental Health Care: A Civil Rights Issue Ralph Ibson, JD Virtual Mentor. 2003;5(10):460-462. doi: 10.1001/virtualmentor.2003.5.10.msoc1-0310. Medical Education Oct 2003 Stigma, Society, and Specialty Choice: What's Going On? Sam Huber Virtual Mentor. 2003;5(10):436-439. doi: 10.1001/virtualmentor.2003.5.10.medu1-0310. Personal Narrative Oct 2003 Understanding Psychotropic Medications as Literary Symbols Jonathan M. Metzl, MD, PhD Virtual Mentor. 2003;5(10):470-472. doi: 10.1001/virtualmentor.2003.5.10.mhum1-0310. Medicine and Society Nov 2021 Home Health Care for Patients Without Shelter Sunil R. Dommaraju, Vanitha Raguveer, Clara Ryan, MS, Justin Ceh, MD, William L. Galanter, MD, PhD, and Evelyn Figueroa, MD Chicago Street Medicine implements HHC to improve health outcomes and care continuity for patients experiencing homelessness. AMA J Ethics. 2021;23(11):E887-892. doi: 10.1001/amajethics.2021.887. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Podcast Apr 2023 Author Interview: “Should Clinicians Care About How Food Behaviors Express Gender Identity?” Dr Whitney Riley Linsenmeyer joins Ethics Talk to discuss her article: “Should Clinicians Care About How Food Behaviors Express Gender Identity?” Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Podcast Nov 2022 Author Interview: “Necessity for and Limitations of Price Transparency in American Health Care” Dr Harold A. Pollack joins Ethics Talk to discuss his article: “Necessity for and Limitations of Price Transparency in American Health Care.”
Case and Commentary Aug 2022 Underrecognition of Dysmenorrhea Is an Iatrogenic Harm Zainab Doleeb, MD, Liam G. McCoy, MD, MSc, Jazleen Dada, MBChB, and Catherine Allaire, MD Underrecognition and lack of awareness about how to help patients with painful menstruation constitute injustice and a health care harm. AMA J Ethics. 2022;24(8):E740-747. doi: 10.1001/amajethics.2022.740.
Podcast Aug 2022 Author Interview: “Underrecognition of Dysmenorrhea Is an Iatrogenic Harm” Dr Liam G. McCoy joins Ethics Talk to discuss his article, coauthored with Drs Zainab Doleeb, Jazleen Dada, and Catherine Allaire: “Underrecognition of Dysmenorrhea Is an Iatrogenic Harm.”
Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612.
Medicine and Society Oct 2003 Access to Mental Health Care: A Civil Rights Issue Ralph Ibson, JD Virtual Mentor. 2003;5(10):460-462. doi: 10.1001/virtualmentor.2003.5.10.msoc1-0310.
Medical Education Oct 2003 Stigma, Society, and Specialty Choice: What's Going On? Sam Huber Virtual Mentor. 2003;5(10):436-439. doi: 10.1001/virtualmentor.2003.5.10.medu1-0310.
Personal Narrative Oct 2003 Understanding Psychotropic Medications as Literary Symbols Jonathan M. Metzl, MD, PhD Virtual Mentor. 2003;5(10):470-472. doi: 10.1001/virtualmentor.2003.5.10.mhum1-0310.
Medicine and Society Nov 2021 Home Health Care for Patients Without Shelter Sunil R. Dommaraju, Vanitha Raguveer, Clara Ryan, MS, Justin Ceh, MD, William L. Galanter, MD, PhD, and Evelyn Figueroa, MD Chicago Street Medicine implements HHC to improve health outcomes and care continuity for patients experiencing homelessness. AMA J Ethics. 2021;23(11):E887-892. doi: 10.1001/amajethics.2021.887.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Podcast Apr 2023 Author Interview: “Should Clinicians Care About How Food Behaviors Express Gender Identity?” Dr Whitney Riley Linsenmeyer joins Ethics Talk to discuss her article: “Should Clinicians Care About How Food Behaviors Express Gender Identity?”